Altshuler Shaham Ltd - KEROS THERAPEUTICS INC ownership

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 112 filers reported holding KEROS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Altshuler Shaham Ltd ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$941,000
-50.4%
34,074
-2.3%
0.01%
-12.5%
Q1 2022$1,896,000
-28.2%
34,863
-23.1%
0.02%
-30.4%
Q4 2021$2,639,000
+46.3%
45,3630.0%0.02%
+76.9%
Q3 2021$1,804,000
+88.5%
45,363
+101.5%
0.01%
+85.7%
Q2 2021$957,000
-31.0%
22,5160.0%0.01%
-50.0%
Q1 2021$1,386,000
-12.8%
22,5160.0%0.01%
-56.2%
Q4 2020$1,589,000
+61.3%
22,516
-11.9%
0.03%
+39.1%
Q3 2020$985,00025,5460.02%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 407,633$12,995,3405.15%
Opaleye Management Inc. 360,400$11,489,5523.74%
Parkman Healthcare Partners LLC 298,475$9,515,3831.74%
BRAIDWELL LP 1,357,309$43,271,0111.37%
First Light Asset Management, LLC 421,438$13,435,4431.28%
Orbimed Advisors 1,514,734$48,289,7201.03%
Yiheng Capital Management, L.P. 554,151$17,666,3340.90%
Nantahala Capital Management 328,781$10,481,5380.90%
DAFNA Capital Management LLC 65,961$2,102,8370.65%
EDBI Pte Ltd 10,105$322,1470.35%
View complete list of KEROS THERAPEUTICS INC shareholders